Globus Medical, Inc.

NYSE:GMED 株式レポート

時価総額:US$11.3b

Globus Medical バランスシートの健全性

財務の健全性 基準チェック /56

Globus Medicalの総株主資本は$4.1B 、総負債は$437.1Mで、負債比率は10.7%となります。総資産と総負債はそれぞれ$5.1Bと$1.0Bです。 Globus Medicalの EBIT は$395.0Mで、利息カバレッジ比率52.1です。現金および短期投資は$694.7Mです。

主要情報

10.7%

負債資本比率

US$437.14m

負債

インタレスト・カバレッジ・レシオ52.1x
現金US$694.71m
エクイティUS$4.07b
負債合計US$1.02b
総資産US$5.09b

財務の健全性に関する最新情報

Recent updates

Globus Medical (NYSE:GMED) Has A Rock Solid Balance Sheet

Nov 04
Globus Medical (NYSE:GMED) Has A Rock Solid Balance Sheet

Globus Medical, Inc.'s (NYSE:GMED) Shareholders Might Be Looking For Exit

Oct 14
Globus Medical, Inc.'s (NYSE:GMED) Shareholders Might Be Looking For Exit

Globus Medical: A Post Acquisition Analysis

Aug 26

Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors

Jun 28
Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Apr 08
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Mar 20
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock

Feb 27

Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Feb 09
Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Jan 17
Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Globus Medical: Merger Overhang Lingering

Nov 27

Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Nov 14
Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Oct 27
Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Globus Medical: Almost Having My Back

Sep 13

Globus Medical: Slightly Too Pricey Right Now

Aug 07

Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy

Jul 18

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jul 11
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Jun 18
Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Apr 09
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Mar 22
What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Feb 24
Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Globus Medical Q4 2022 Earnings Preview

Feb 20

Globus Medical: An Impressive Long-Term Revenue Growth Play

Jan 08

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Dec 22
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Dec 01
Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line

Nov 08

A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Oct 15
A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact

Sep 02

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Sep 02
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Aug 11
Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective

Jun 05

Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

May 24
Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

財務状況分析

短期負債: GMEDの 短期資産 ( $2.1B ) が 短期負債 ( $818.1M ) を超えています。

長期負債: GMEDの短期資産 ( $2.1B ) が 長期負債 ( $198.6M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: GMED総負債よりも多くの現金を保有しています。

負債の削減: GMEDの負債対資本比率は、過去 5 年間で0%から10.7%に増加しました。

債務返済能力: GMEDの負債は 営業キャッシュフロー によって 十分にカバー されています ( 94.9% )。

インタレストカバレッジ: GMEDの負債に対する 利息支払いEBIT ( 52.1 x coverage) によって 十分にカバーされています


貸借対照表


健全な企業の発掘